Literature DB >> 34302623

Cholecystectomy as a risk factor for metabolic dysfunction-associated fatty liver disease: unveiling the metabolic and chronobiologic clues behind the bile acid enterohepatic circulation.

Li Qi1, Wanlin Dai2, Jing Kong3, Yu Tian3, Yongsheng Chen4.   

Abstract

Metabolic dysfunction-associated fatty liver disease (MAFLD) is highly prevalent worldwide. Recent clinical and experimental studies have addressed the association between cholecystectomy and MAFLD, confirming that cholecystectomy is an independent risk factor for MAFLD. In this review, we describe the epidemiologic evidence that links cholecystectomy to MAFLD, and discuss the possible mechanisms behind these connections, in order to unveil the metabolic and chronobiologic signals conveyed by the waves of the bile acid enterohepatic circulation.
© 2021. University of Navarra.

Entities:  

Keywords:  Bile acid; Cholecystectomy; Circadian rhythm; Gallbladder; Metabolic dysfunction-associated fatty liver disease

Mesh：

Substances：

Year:  2021        PMID： 34302623     DOI： 10.1007/s13105-020-00782-w

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN： 1138-7548            Impact factor:   4.158


  90 in total

1.  Association between cholecystectomy for gallstone disease and risk factors for cardiovascular disease.

Authors:  Norberto C Chavez-Tapia; Ileana Mac Kinney-Novelo; Sergio E Sifuentes-Rentería; Maximiliano Torres-Zavala; Gildardo Castro-Gastelum; Karla Sánchez-Lara; Carla Paulin-Saucedo; Misael Uribe; Nahum Méndez-Sánchez
Journal:  Ann Hepatol       Date:  2012 Jan-Feb       Impact factor: 2.400

2.  The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology.

Authors:  Naga Chalasani; Zobair Younossi; Joel E Lavine; Anna Mae Diehl; Elizabeth M Brunt; Kenneth Cusi; Michael Charlton; Arun J Sanyal
Journal:  Gastroenterology       Date:  2012-05-15       Impact factor: 22.682

3.  Cholecystectomy increases hepatic triglyceride content and very-low-density lipoproteins production in mice.

Authors:  Ludwig Amigo; Constanze Husche; Silvana Zanlungo; Dieter Lütjohann; Marco Arrese; Juan Francisco Miquel; Attilio Rigotti; Flavio Nervi
Journal:  Liver Int       Date:  2010-10-29       Impact factor: 5.828

4.  Metabolic master regulators: sharing information among multiple systems.

Authors:  Barbara E Corkey; Orian Shirihai
Journal:  Trends Endocrinol Metab       Date:  2012-08-30       Impact factor: 12.015

5.  Weight gain after laparoscopic cholecystectomy.

Authors:  R B Ali; R A Cahill; R G K Watson
Journal:  Ir J Med Sci       Date:  2004 Jan-Mar       Impact factor: 1.568

Review 6.  Intestinal microbiota and nonalcoholic steatohepatitis.

Authors:  Katharina Brandl; Bernd Schnabl
Journal:  Curr Opin Gastroenterol       Date:  2017-05       Impact factor: 3.287

7.  Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration.

Authors:  Gloria Alvarez-Sola; Iker Uriarte; M Ujue Latasa; Maite G Fernandez-Barrena; Raquel Urtasun; Maria Elizalde; Marina Barcena-Varela; Maddalen Jiménez; Haisul C Chang; Roberto Barbero; Victoria Catalán; Amaia Rodríguez; Gema Frühbeck; José M Gallego-Escuredo; Aleix Gavaldà-Navarro; Francesc Villarroya; Carlos M Rodriguez-Ortigosa; Fernando J Corrales; Jesus Prieto; Pedro Berraondo; Carmen Berasain; Matias A Avila
Journal:  Gut       Date:  2017-01-24       Impact factor: 23.059

8.  Effect of cholecystectomy on bile acid synthesis and circulating levels of fibroblast growth factor 19.

Authors:  Francisco Barrera; Lorena Azócar; Héctor Molina; Kurt A Schalper; Marcia Ocares; Jessica Liberona; Luis Villarroel; Fernando Pimentel; Rosa M Pérez-Ayuso; Flavio Nervi; Albert K Groen; Juan F Miquel
Journal:  Ann Hepatol       Date:  2015 Sep-Oct       Impact factor: 2.400

9.  The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.

Authors:  Jérôme Boursier; Olaf Mueller; Matthieu Barret; Mariana Machado; Lionel Fizanne; Felix Araujo-Perez; Cynthia D Guy; Patrick C Seed; John F Rawls; Lawrence A David; Gilles Hunault; Frédéric Oberti; Paul Calès; Anna Mae Diehl
Journal:  Hepatology       Date:  2016-01-13       Impact factor: 17.425

10.  Asynchronous rhythms of circulating conjugated and unconjugated bile acids in the modulation of human metabolism.

Authors:  A Al-Khaifi; S Straniero; V Voronova; D Chernikova; V Sokolov; C Kumar; B Angelin; M Rudling
Journal:  J Intern Med       Date:  2018-07-31       Impact factor: 8.989
View more
  1 in total

1.  Cholecystectomy-induced secondary bile acids accumulation ameliorates colitis through inhibiting monocyte/macrophage recruitment.

Authors:  Yun Liu; Jun Xu; Xinhua Ren; Yu Zhang; Ziliang Ke; Jianhua Zhou; Yang Wang; Yifan Zhang; Yulan Liu
Journal:  Gut Microbes       Date:  2022 Jan-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.